Wednesday, September 17 - ET (Eastern Time, GMT-05:00)
CPE Credits Available: 0.3
- Mallory Morales - Chief Accounting Officer, Immuneering
- Market outlook
- Deals and trends
- What to expect in regard to tariffs
- New administration impacts on life sciences
CPE Credits Available: 1.2
- Business development opportunities & fundraising strategies
- Collaborations, mergers, partnering
- Career path
- Career advancement
- Non-traditional and traditional upleveling techniques
- Top of mind for leadership in 2025 and beyond
CPE Credits Available: 1.2
- Sophia Shah - Partner, Tax, Crowe LLP
- Colleen Tupper - Chief Financial Officer, Collegium
- Jon Freve - Chief Financial Officer, Alentis Therapeutics
- Rakhi Kumar - Board Member, Neuropace
- Daniel Rosan - Chief Financial Officer, Ascidian Therapeutics
- Cost estimation
- Resource allocation
- Risk management
- Compliance
- Reimbursement
- Trial design impact
CPE Credits Available: 1.2
- Jennifer Kyle - Founder and CEO, Condor Software
- Juan Betanzo - Vice President, Strategic Finance, EyePoint
- Chedvi Sister - VP, Finance, Immunovant
- Allison Richards - Executive Director, FP&A, BridgeBio
- Valuations
- Different market requirements whether public or private
- Methods for valuation modeling
- Scenario planning
- Cash runway management
CPE Credits Available: 1.2
- Catherine Chan, Independent
- Patrick Coyle - Founder, Novus Proximus
- Julio Martinez - CEO, Co-Founder, Abacum
- Revenue Recognition
- ACS 606 Compliance
- Licensing arrangements
- R&D Accounting
- Expense capitalization vs. Expensing
- Collaboration agreements
- GHG Emissions
- Overview of Scope 1, 2, and 3
- Calculations & how they are factored
CPE Credits Available: 1.2
- David Pieters - Vice President , Finance, Biotheryx
- Sarah Stiff - ESG Controller, Legend Biotech
- Marc Siegel - Former Board Member, FASB & SASB
Life Sciences organizations are accelerating their use of the cloud to power digital transformation across clinical trials, drug discovery and real-world evidence. However, this surge in cloud adoption can bring rapid increases in unpredictable costs that strain R&D budgets, regulatory compliance considerations, and the complexities of cloud economics. Join us to explore how cloud financial management and FinOps practices can help Life Sciences leaders gain visibility, control spending, and ensure cloud investments directly support scientific innovation and operational efficiency at scale. Presentation Topics:
- Understand FinOps for Regulated Environments: Decode how cloud billing works across AWS, Azure, and Google Cloud, and how to apply FinOps best practices to budgeting, forecasting and chargebacks, while maintaining compliance with FDA, GxP, HIPAA, and global data privacy regulations.
- Applying Financial Governance in Single or Multi Cloud Environments: Control spending for diverse trial workloads — including R&D Pipelines, Genomics, AI/ML, Digital BioMarkers, and Multi Region Clinical Data Lakes. Align cloud investments with drug pipeline milestones and allocate costs for Research teams.
- Creating Financial Accountability Across Teams: Enhance collaboration between finance, data science, clinical IT, and regulatory groups with reporting and dashboard tools that provide visibility into cloud economics.
- Case Study: Driving Business Value from Cloud Investments
CPE Credits Available: 1.2
- Monica Wezwick - Enterprise Cloud Strategy Advisor, Sublimation Health
- Writing emails and policies
- Accounting operations automation
- Daily activities where users see benefit
CPE Credits Available: 1.2
- Lina Parra Cartagena - Associate Director, Finance, Vertex Pharmaceutical
- Oksana Kamparosyan - Senior Solutions Consultant, Sage Intacct, Inc.
Unlock Your Launch Potential: GTN Training for Emerging Biopharma
Ready to transform your first commercial launch into a success story? Our GTN Training equips emerging biopharma teams with the essential building blocks for launch excellence — from crafting the right organizational structure to aligning finance and commercial goals, and developing a winning product, pricing, distribution, and reimbursement strategy.
Learn how to anticipate compliance requirements, master the GTN process, and confidently forecast with real-world analogs and analytics with this 4 part series.
Gain the knowledge, tools, and insights you need to build a scalable foundation — and set your product up for lasting success.
Course 3: Crafting Smart Pricing & Contracting Strategies
- How to align Phase III data with contracting and payer needs
- How to develop pricing models that balance access and profitability
- How to forecast and accrue accurately using real-world analogs
CPE Credits Available: 2.0
- Patrick Coyle - Founder, Novus Proximus